Private Equity

Emcure Pharmaceuticals shares listed at Rs 1,325.05 on NSE, a 31.45% premium over the issue price of Rs 1,008.  The stock also listed at the same price and premium on BSE, aligning with investor ex...

Welcome to News Discussion's Private Community

- Emcure Pharmaceuticals shares listed at Rs 1,325.05 on NSE, a 31.45% premium over the issue price of Rs 1,008.
- The stock also listed at the same price and premium on BSE, aligning with investor expectations.
- Ahead of the listing, shares had a grey market premium of Rs 300, indicating a 30% listing pop.
- The IPO, open from July 03 to July 05, raised Rs 1,952.03 crore, including a fresh share sale of Rs 800 crore.
- The issue was subscribed 67.87 times overall, with QIBs booking 195.83 times, non-institutional investors 48.32 times, retail investors 7.21 times, and employees 8.81 times. 

 Source: Business Today

Emcure Pharma Shares Make Strong Debut with 31% Premium

Journalist

Emcure Pharma Shares Make Strong Debut with 31% Premium- Grapevine

- Shares of kids-focused omnichannel retailer FirstCry made a strong debut on the exchanges today, opening higher than the issue price.
- On the NSE, shares of FirstCry’s parent Brainbees Solutions opened at INR 651, at a premium of 40% over its issue price of INR 549. On the BSE, it listed at INR 625, reflecting a 34.4% premium.
- FirstCry has set a price range of INR 440 to INR 465 per equity share for the IPO. At the upper end of the band, Brainbees Solutions intends to raise INR 4,193 Cr.
- The omnichannel baby and kids marketplace raised INR 1,885.82 Cr from anchor investors at INR 465 per equity share, with participation from major investors like the Government of Singapore and Abu Dhabi Investment Authority.
- FirstCry’s market capitalization stands at INR 6,934.74 Cr as of today. 

 Source: [Inc42](https://inc42.com/buzz/firstcry-shares-list-at-40-premium-over-ipo-price-on-debut/)

FirstCry Shares List At 40% Premium Over IPO Price On Debut

- Unicommerce eSolutions Ltd made a strong debut on the NSE, listing shares at Rs 235 each, a 117.6% premium over the IPO price of Rs 108.
- The IPO, a book-built issue of Rs 276.6 crore, was open for subscription from August 6 to August 8 and was subscribed 168.35 times by the last day.
- Retail investor portion was subscribed 130.9 times, QIBs 138.75 times, and NIIs 252.46 times.
- The IPO is entirely an offer-for-sale of 2.6 crore shares, with a price band set between Rs 102 and Rs 108 per share.
- Established in February 2012, Unicommerce eSolutions operates a SaaS platform that streamlines e-commerce operations for brands, sellers, and logistics providers. 

 Source: [Moneycontrol](https://www.moneycontrol.com/news/business/ipo/unicommerce-esolutions-makes-stellar-market-debut-as-shares-list-at-118-premium-12794689.html)

Unicommerce eSolutions Makes Stellar Market Debut with 118% Premium Listing

- Jaipur-based D2C men’s grooming brand Menhood is set to go public with an NSE Emerge listing.
- The IPO will open on July 16 and close on July 19, with a price band of INR 71-75 per share.
- Menhood aims to raise INR 19.5 Cr at the upper end of the price band, offering 25,95,200 equity shares.
- Proceeds will be used to expand product offerings and enhance operational capabilities.
- Menhood will be the third new-age startup to list on NSE Emerge this year, following TAC Infosec and Trust Fintech. 

 Source: Inc42

Menhood's IPO Opens on July 16, Listing on NSE Emerge

- Infra.Market, backed by Tiger Global and Accel, has chosen eight investment banks for its upcoming IPO, aiming to raise over $500 million.
- The selected banks include Kotak Mahindra Capital, IIFL Capital, Goldman Sachs, Jefferies, ICICI Securities, HSBC Securities, Motilal Oswal Financial Services, and Nuvama Wealth Management.
- The IPO is expected to be a mix of fresh issue and secondary sales, providing an exit for top VC investors.
- The issue size is projected to be between $500 million and $700 million, with potential for a higher amount based on market conditions.
- Infra.Market's subsidiary, RDC Concrete, plans its own public market debut in January 2025 after divesting a 10% stake worth $20 million in 2023. 

 Source: [Moneycontrol](https://www.moneycontrol.com/news/business/ipo/tiger-global-accel-backed-infra-market-picks-8-i-bankers-for-mega-500-mn-plus-ipo-12811099.html)

Infra.Market Selects 8 Investment Banks for $500M+ IPO

- IndiQube is in advanced talks to finalize merchant bankers and aims to file its DRHP within three months.
- The startup plans to raise INR 1,000 Cr – INR 1,500 Cr from its IPO, mainly through fresh share issuance.
- IndiQube posted a profit of INR 60 Cr in FY24 on an operating revenue of around INR 850 Cr.
- Founded in 2015, IndiQube offers managed office spaces and counts WestBridge Capital and Helion Ventures among its backers.
- The company competes with Awfis and Smartworks, with the latter also filing its DRHP recently. 

 Source: [Inc42](https://inc42.com/buzz/exclusive-coworking-space-provider-indiqube-in-talks-with-bankers-for-inr-1500-cr-ipo/)

IndiQube Eyes INR 1,500 Cr IPO Amidst Indian Bourse Boom

Welcome to Indian Startups's Private Community

There’s no way MamaEarth is worth 10,000 crores, I mean their products are shit, they don’t even manufacture their own products, they don’t have any patents. It’s essentially just a marketing company who have managed to sell mediocre products under the disguise of “toxin-free”.
I really wished their IPO would fail 🥲

Is Mamaearth another story of VCs making a shit ton of money at the expense of retail investors ?

Welcome to Personal Finance's Private Community

I got alloted the IPO. It's my first time. I had researched about the company and looked good to me. After reading a lot(and overthinking!) had decided to go for it.

The share is listing tomorrow soo what are the sentiments and predictions of listing price?😛

Motison Jewellery IPO

Business Analyst

- Delhivery has publicly disputed the accuracy of metrics in Ecom Express' IPO prospectus.
- The SoftBank-backed firm claims Ecom Express misrepresented Delhivery's business metrics.
- Delhivery alleges Ecom Express inflates shipment figures by counting returns as two shipments.
- The firm also contests Ecom Express' cost per shipment calculations and zipcode coverage claims.
- This dispute arises as Ecom Express aims to raise $310 million in its upcoming IPO. 

 Source: [Techcrunch](https://techcrunch.com/2024/09/13/softbank-backed-delhivery-contests-metrics-in-rival-ecom-express-ipo-filing/)

Delhivery Challenges Ecom Express' IPO Metrics

The Morning Vine 🍇

"I wonder how Jefferies has given a target price of Rs. 520/share on Mamaearh - on the listing day, it was already at 93.5 times EBITDA" -> Need more people like this on LinkedIn!

Product Manager

Stock

Product Owner

Amidst global recession, specially for IT companies, Indegene is floating an initial public offering (IPO) in April 24! Thoughts on the subscription?

Program Manager

https://economictimes.indiatimes.com/tech/startups/pharmeasy-plans-rs-2400-crore-rights-issue-at-90-cut-in-share-price/articleshow/101510154.cms

Pharmeasy with a 90% cut in valuation

Software Engineer

Horrific scenes in the Indian startup ecosystem. From being on the verge of an IPO to raising an emergency round which shall lead to the sudden death of employee ESOPs. Crores of wealth destroyed for the employees.

A chain reaction of horror is about to unfold for late stage startups.

90% downround Pharmeasy

- Blackbuck, a logistics unicorn, has filed a draft red herring prospectus for a fresh issue of Rs 550 crore and an offer for sale of 2.16 crore shares.
- Key investors selling shares in the IPO include Accel (52 lakh shares), Tiger Global (9 lakh shares), Flipkart (4 lakh shares), and IFC (17 lakh shares).
- Founders Rajesh Yabaji, Chanakya Hridaya, and Ramasubramanian Balasubramaniam will also sell a combined total of 44 lakh shares.
- Blackbuck's revenue rose 69% from Rs 176 crore in FY23 to Rs 297 crore in FY24, while net loss narrowed from Rs 290 crore to Rs 194 crore.
- The IPO proceeds will fund marketing, product development, its NBFC arm, and general corporate purposes.

Blackbuck Files IPO Prospectus for Rs 550 Crore Fresh Issue

Meesho ESOPs

Growth Manager

- 360 One Asset, an investor in India's National Stock Exchange (NSE), has increased its valuation of the stock exchange to $29.9 billion.
- This new valuation is significantly higher than the $18 billion to $19 billion price tag from private transactions last year.
- The wealth manager disclosed this updated valuation in June, reflecting growing confidence in India's economic prospects and a surge in public listings.
- NSE reported a revenue of $1.94 billion for the financial year ending in March, a 28% increase from the previous year.
- The increase in valuation highlights India's growing prominence in global financial markets, with NSE being the world's largest derivative exchange. 

 Source: [Techcrunch](https://techcrunch.com/2024/08/23/360-one-lifts-its-valuation-of-indias-national-stock-exchange-to-29-9b/)

Emcure Pharma Shares Make Strong Debut with 31% Premium

Discover More

News Discussion on

by Coy Lee

Grapevine

FirstCry Shares List At 40% Premium Over IPO Price On Debut

News Discussion on

by Karilyn Carmden

Grapevine

Unicommerce eSolutions Makes Stellar Market Debut with 118% Premium Listing

News Discussion on

by Matilda Carmden

Grapevine

Menhood's IPO Opens on July 16, Listing on NSE Emerge

News Discussion on

by Isaiah Lee

Grapevine

Infra.Market Selects 8 Investment Banks for $500M+ IPO

News Discussion on

by Karilyn Olive

Grapevine

IndiQube Eyes INR 1,500 Cr IPO Amidst Indian Bourse Boom

Indian Startups on

by Blair Dean

Student

Is Mamaearth another story of VCs making a shit ton of money at the expense of retail investors ?

Personal Finance on

by Aaron Gabriel

Amazon

Motison Jewellery IPO

News Discussion on

by Kalan Lee

Grapevine

Delhivery Challenges Ecom Express' IPO Metrics

News Discussion on

by Kendall Everett

Grapevine

The Morning Vine 🍇

Personal Finance on

by Matilda Everett

Citymall

"I wonder how Jefferies has given a target price of Rs. 520/share on Mamaearh - on the listing day, it was already at 93.5 times EBITDA" -> Need more people like this on LinkedIn!

Personal Finance on

by Isaiah Denver

City Mall

Stock

Indian Startups on

by Jordon Carmden

Indegene

IPO

Indian Startups on

by Kendall Nadeen

Stealth

Pharmeasy with a 90% cut in valuation

Indian Startups on

by Jordon Everett

Stealth

90% downround Pharmeasy

News Discussion on

by Coy Lee

Grapevine

Blackbuck Files IPO Prospectus for Rs 550 Crore Fresh Issue

Indian Startups on

by Kendall Lee

CARS24

Meesho ESOPs

News Discussion on

by Isaiah Lee

Grapevine

360 One Lifts Valuation of India's National Stock Exchange to $29.9B